Janssen-Cilag AG - Risperdal Consta 25 mg, Suspension zur i.m. Applikation | | 56092 | | 01 | | Risperdal Consta 25 mg | | Suspension zur i.m. Applikation | | N05AX08 | | Risperidone | | 26.06.2002 | | |
| Composition | Praeparatio sicca: risperidonum 25 mg, poly(lactidum-co-glycolidum).
Solvens: carmellosum natricum, polysorbatum 20, dinatrii phosphas dihydricus, acidum citricum, natrii chloridum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 2 ml, pro vase, in suspensione recenter reconstituta corresp. natrium 9.872 mg. | Packungsbestandteile | | Injektionssuspension | | | Active Agent | Dose | additional_information |
---|
Risperidon | 25 mg | Praeparatio sicca |
| BAG: Active Agent | Dose |
---|
Risperidon | 25 mg |
| | Inactive agents |
---|
Poly(Lactidum-Co-Glycolidum) |
| |
| Solvens | | | Injektionssuspension | | | | | | | BAG: Active Agent | Dose |
---|
Risperidon | 25 mg |
| | Inactive agents |
---|
Acidum Citricum | Carmellosum Natricum | Dinatrii Phosphas Dihydricus | Natrii Chloridum | Natrii Hydroxidum | Polysorbatum 20 |
| |
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
---|
001 | Set(s) | 98.36 | 121.80 | B | SL | Yes |
|
|